Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia January 31, 2025 Scoping review identifies factors associated with the onset of infant acute lymphoblastic leukaemia
The VESIPROD team is working with Dr. Gaël Roué's lab to present its prototype to the iGEM synthetic biology competition July 20, 2022 The VESIPROD team is working with Dr. Gaël Roué's lab to present its prototype to the iGEM synthetic biology competition
A new method developed by researchers from the Josep Carreras Institute predicts childhood hyperdiploid B-ALL relapse risk July 07, 2022 A new method developed by researchers from the Josep Carreras Institute predicts childhood hyperdiploid B-ALL relapse risk
National experts in cytogenetic diagnosis of leukemia meet at the Josep Carreras Institute to discuss the present and future of Optical Genome Mapping July 05, 2022 National experts in cytogenetic diagnosis of leukemia meet at the Josep Carreras Institute to discuss the present and future of Optical Genome Mapping
Researchers at the Josep Carreras Institute will study a rare T-cell lymphoma thanks to the Leukemia Research Foundation July 01, 2022 Researchers at the Josep Carreras Institute will study a rare T-cell lymphoma thanks to the Leukemia Research Foundation
The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program June 29, 2022 The pro-B-ALL project led by Dr. Maribel Parra is selected by the i4KIDS Pediatric Hub as a finalist in its Innovation Program
Discovered epigenetic alterations associated with the COVID-19 related severe inflammatory syndrome in childhood June 27, 2022 Discovered epigenetic alterations associated with the COVID-19 related severe inflammatory syndrome in childhood
Cancer vs. the immune system: macroH2A, a chromatin protein, can turn cancer cells deaf to immune commands June 22, 2022 Cancer vs. the immune system: macroH2A, a chromatin protein, can turn cancer cells deaf to immune commands
Genetic information from myelodysplastic syndromes’ patients incorporated in the latest update of the international standard risk assessment metric: the IPSS-M June 20, 2022 Genetic information from myelodysplastic syndromes’ patients incorporated in the latest update of the international standard risk assessment metric: the IPSS-M
Mission Bio names Josep Carreras Leukaemia Research Institute as First Center of Excellence for Tapestri Platform in Europe June 15, 2022 Mission Bio names Josep Carreras Leukaemia Research Institute as First Center of Excellence for Tapestri Platform in Europe
A new fast and reliable experimental model for vascular malformations leads to the identification of miransertib as a promising therapy option June 14, 2022 A new fast and reliable experimental model for vascular malformations leads to the identification of miransertib as a promising therapy option
